Black men carry the disproportionate burden of prostate cancer occurrences in the U.S. and have the highest documented prostate cancer rate in the world. Cancer deaths among Black men represent the greatest mortality disparity in oncology. We believe no one should be at a disadvantage against cancer, and we must address the challenge with great urgency.
The American Cancer Society (ACS) and our nonpartisan advocacy affiliate, American Cancer Society Cancer Action Network (ACS CAN), are uniquely positioned to address these alarming disparities through our new IMPACT initiative – Improving Mortality from Prostate Cancer Together.
We must address these shifts in prostate cancer, especially in the Black community, since the incidence of prostate cancer in Black men is 70% higher than in White men. IMPACT will fund bold new cancer research programs that connect the laboratory, the clinic, and the community.
With IMPACT, we are committed to using every facet of our organization to reverse prostate cancer disparities and reduce death rates from prostate cancer in Black men by 2035:
Health equity is embedded in our mission and eliminating disparities is at the forefront of our work. Through IMPACT, we are reaffirming our commitment to eliminating barriers and addressing needs to ensure everyone has the same opportunity to be healthy and cancer-free.
Learn more about our comprehensive commitment to end cancer as we know it, for everyone: